(PharmaNewsWire.Com, November 16, 2018 ) The market for the structural heart was valued at US$ 6,406.3 in 2017 and is expected to reach US$ 13,850.2 Mn in 2025. The market is estimated to grow with a CAGR of 10.5% from 2017-2025.
In our study of structural heart market is segmented into three major segments such as product, procedure, and end user. The product segment is divided into occluders, annuloplasty rings, heart valve balloons and others. The procedures segment consists of surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair and left atrial appendage closure. Similarly, the end user is classified as hospitals and ambulatory surgical centers and cardiac centers.
The devices for the structural heart are designed to remold or repair the valvular heart abnormalities, defects and diseases. The market for the structural heart devices is developing as the prevalence for the structural heart diseases are estimated to be rising in the coming future. The targeted stakeholders for the reports include suppliers and distributors of structural heart devices and structural heart device manufacturing companies, hospitals and cardiac centers, healthcare professionals, ambulatory surgery centers and others.
The objective or the scope the study for structural heart market was defining, describing, and forecasting the structural heart market on the basis of product, procedure, end user and region. In addition, analyzing the market structure, profiling the key players of the market, and comprehensively analyzing their core competencies. Tracking and analyzing competitive developments such as new product launches; market consolidations and clinical trials in the structural heart market. Moreover, the aim of the study was providing detailed information regarding the major factors or the reasons that are influencing the growth of the market in the five major regions such as North America, Europe, Asia Pacific, Middle East and Africa and South and Central America.
The structural heart market in different regions is analyzed by the PEST analysis and the SWOT analysis is provided for the profiled companies in our scope of study. For instance, the PEST analysis of the North America region contain political factor – tracking congenital heart defects (CHDs) programs, the economic factor - reimbursements plans for structural heart treatment, social factor – various fellowship programs in US, and the technological factor – developments for the treatment of severe aortic stenosis. Thus, the structural heart market report provides all the major factors, such as drivers, restraints, opportunities, trends that are impacting the growth of the structural heart in the forecasted period.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
